Massy, Ziad

France
Langues d'expression
français
Professeur des universités, praticien hospitalier, services de pharmacologie clinique et de néphrologie, Centre hospitalier universitaire, Amiens (en 2004). Directeur de Thèse en 2009 à l'Université de Pierre et Marie Curie-Paris 6. Travaille à l'Université Versailles Saint-Quentin (Université Paris Saclay) en 2019

MASSY Ziad, Boulogne-Billancourt, FRA<br>Ziad A. Massy MD, PhD, FERA is : Professor of Nephrology and Head of the Division of Nephrology at the Paris Ouset University (UVSQ)- Ambroise Paré Hopsital, Paris, and Director of Research Unit INSERM U-1088 at the UPJV, Amiens, France.
Professor Massy is a current Ordinary Council Member of ERA-EDTA and Chair of the ERA-EDTA International Committee, and is a current member and former cochairman of the European Uremic Toxins group, Coremember of the EURECAM Working Group Advisory Board– ERA-EDTA, Core-member of the CKD-MBD Working Group Advisory Board–ERA-EDTA, as well as Board member of the Council of EVBO (European Vascular Biology Organisation). In September 2010, he was presented with the Fondation du Rein Award. He is on the editorial boards of Kidney
International, NDT, Journal of Renal Nutrition, Journal of Nephrology and Néphrologie et Thérapeutique (where he served as Editor in Chief from 2007 to 2010, and is currently Emeritus Editor). His research areas of special interest include cardiovascular disease, vascular calcifications, hyperlipidemia, uremic toxins, oxidative stress, and chronic renal failure. He has published many original articles, reviews and chapters of books in his domain of interest.

Vidéos

Cardiovascular Clinical Trialists (CVCT) Forum – EVOLVE: A major cardiovascular outcomes trial in hemodialysis patients (debates).
Conférence
00:09:24

Cardiovascular Clinical Trialists (CVCT) Forum – EVOLVE: A major cardiovascular outcomes trial in h…

Massy
Ziad

Title : Cardiovascular Clinical Trialists (CVCT) Forum – EVOLVE: A major cardiovascular outcomes trial in hemodialysis patients (debates). Speakers: Chris MIX, Amgen, USA - David WHEELER, London, GBR

Cardiovascular Clinical Trialists (CVCT) Forum – EVOLVE: A major cardiovascular outcomes trial in hemodialysis patients
Conférence
00:10:30

Cardiovascular Clinical Trialists (CVCT) Forum – EVOLVE: A major cardiovascular outcomes trial in h…

Massy
Ziad

Title : Cardiovascular Clinical Trialists (CVCT) Forum – EVOLVE: A major cardiovascular outcomes trial in hemodialysis patients Speakers: Chris MIX, Amgen, USA - David WHEELER, London, GBR Discussant: